fundmomentum.vc

Claris Biotech II

Italy
Pre Seed
Share

About Claris Biotech II

Claris Biotech II is a venture capital firm based in Italy, focusing on Pre-Seed stage investments. The fund actively supports founders building innovative solutions in Biotech, Deep Tech, SaaS, providing strategic guidance and capital to help startups scale.

Investment Focus

Location / RegionItaly
Funding StagePre Seed
Industry Focus
Biotech
Deep Tech
Saas

Investor Signals Profile

active

Sweet Spot

Early-stage biopharma founder with clear vision, solid science

early-stage biopharma
oncology
rare diseases
immunology
RNA & CNS therapies
obesity
respiratory
cardiac regeneration
immunotherapy
life-threatening indications

Bullish Signals

11 portfolio companies across biopharmaexternal
EU Horizon 2020 & EFSI backed fundexternal
EIF AlpGIP & Pan-European Guarantee Fund supportexternal
Oncology, RNA, CNS, immunology coverageexternal
Active EIR signals co-building capacitywebsite
Respiratory, cardiac, metastasis — broad bio coveragewebsite
11 named portfolio companies confirmed livewebsite
Haptena added — immuno-oncology expansionwebsite
Obesity & metabolic diseases added to focus areaswebsite
Resalis obesity ncRNA platform signals new thesis expansionwebsite
Capital, competence, hands-on clinical dev supportwebsite
Kither respiratory, NeoPhore immunotherapy, Page metastasiswebsite

Contrarian Signals

Narrow biopharma-only mandateexternal
Italy-based, European deal focusexternal
No exits publicly visible yetexternal

Founder Do's

Show solid scientific evidence upfront
Address strong unmet clinical need
Focus on rare disease, oncology, or immunology
Be ready for hands-on clinical dev support
Seek EU-backed capital partnerships

Founder Don'ts

No digital health or non-biopharma pitches
No pre-scientific or idea-stage companies
No markets without life-threatening indication

Key GPs & Partners

PP
Pietro Puglisi
Managing Partner
biopharma-focusedhands-onclinical-stage
CS
Ciro Spedaliere
Managing Partner
biopharma-focusedhands-onclinical-stage
GV
Giulia Vestri
Partner
biopharmainvestment
PV
Paolo Vigo
Investment Manager
deal executionbiopharma
GP
Gianmarco Pallavicini
Senior Associate
biopharmadeal support
GM
Giuditta Magnifico
Associate
biopharmainvestment
RT
Raffaele Troya
Finance & Administration Manager
financeadministration
AA
Araceli Albano
Internal Accounting & Administration
accountingadministration
RDP
Roberto De Ponti
Senior Advisor
advisorbiopharma
LF
Laura Iris Ferro
Senior Advisor
advisorbiopharma
MM
Manilo Marocco
Senior Advisor
advisorbiopharma
MH
Michael Hodges
Entrepreneur in Residence
operatorbiopharma
LM
Luca Melindo
Advisor
advisorbiopharma
CT
Cristina Tumiatti
Independent Director
governanceindependent

Unlock Investor Signals

$29/month for full signal access. Cancel anytime.

View PlansBrowse all Signal Profiles →

Fund Overview

Fund Size€100M
Saves0
Website
LinkedIn

Key People

Ciro Spedaliere, Ietro Uglisi

Pietro PuglisiManaging Partner
Ciro SpedaliereManaging Partner
Giulia VestriPartner
Paolo VigoInvestment Manager
Gianmarco PallaviciniSenior Associate
Giuditta MagnificoAssociate
Raffaele TroyaFinance & Administration Manager
Araceli AlbanoInternal Accounting & Administration
Roberto De PontiSenior Advisor
Laura Iris FerroSenior Advisor
Manilo MaroccoSenior Advisor
Michael HodgesEntrepreneur in Residence
Luca MelindoAdvisor
Cristina TumiattiIndependent Director

Related Funds

Techshop Fund I.

€53M
Italy
Pre Seed
Saas
Fund Manager:Aurelio Mezzotero, Gianluca D’agostino
Pre Seed
Saas

Prana101

€100
Italy
Pre Seed
Fund Manager:Andrea Di Camillo, Lisa Di Sevo, Guido Giordano
Pre Seed

Programma 103 (P101 SGR)

€250M
Italy
Series A
Saas, Ai Ml, Climate Sustainability, Digital Education Consumer
Fund Manager:Andrea Di Camillo, Giuseppe Donvito
Series A
Saas
Ai Ml
Climate Sustainability
Digital Education Consumer